CAR-T Patient Derived Equipment
1 equipment items found
-
based in USA
of the target cell via the CAR, the CAR-T cell kills the targeted cell. CAR-T cells have demonstrated great success in the clinic, but currently marketed therapies are derived from a patient’s own cells and are therefore available to a limited patient population. We are developing differentiated, off-the-shelf CAR-T cell therapies, ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you